| Literature DB >> 34335542 |
Jian Wang1, Sujie Liu1, Jiayu Ma1, Xiangshu Piao1.
Abstract
Xylanase exerts key roles in improving growth performance and intestinal health of broilers fed wheat-based diets. However, knowledge is limited regarding effects of xylanase supplementation on ileal microbiota in broilers. A total of 128 one-day-old broilers (initial BW 48.03 ± 0.33 g) were selected to investigate effects of xylanase (AT-xynA) on growth performance, ileal morphology, microbiota composition, immune response, antioxidant capacity, and endocrine peptide levels in broilers. Broilers were randomly allotted into two dietary treatments (n = 8), namely, a wheat-soybean basal diet and a basal diet with 4,000 U/kg AT-xynA (XY). On days 7, 14, 21, and 42, broilers were weighted and ileal tissues were sampled. Ileal digesta samples were collected for analyzing microbiota composition on days 21 and 42. The results showed that AT-xynA could improve average daily weight gain and average daily feed intake, and there were interactions between diet and age of broilers (p < 0.05). On days 21 and 42, xylanase supplementation decreased ileal microbiota α-diversity, and the relative abundance of potentially pathogenic microbiota, such as phylum Proteobacteria, family Moraxellaceae and Staphylococcaceae, genus Staphylococcus, Pseudomonas, Streptococcus, and Enterococcus, increased the abundance of Lactobacillus (p < 0.05). Moreover, the reduction in acetate concentration and abundance of short-chain fatty acid-producing bacteria was also observed in broilers from XY group (p < 0.05). AT-xynA increased ileal villus height, glucagon-like peptide-1, and insulin-like growth factor-1 concentrations and decreased interleukin-1β, interleukin-6, tumor necrosis factor-α, and malondialdehyde content in broilers, and these positive effects on intestinal health were greater in young broilers. In conclusion, xylanase supplementation to wheat-based diets could improve ileal intestinal morphology and immune function, and alleviate excess fermentation of bacteria, which may be related to changes of intestinal microbiota. In addition, the positive effects of xylanase on intestinal health were more pronounced in young broilers, thus contributing to subsequent improvement in growth performance of broilers.Entities:
Keywords: broiler; ileal; microbiota; wheat; xylanase
Year: 2021 PMID: 34335542 PMCID: PMC8319766 DOI: 10.3389/fmicb.2021.706396
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Composition and nutrient levels of basal diets (%, as-fed basis).
| Item | days 0–21 | days 21–42 |
|---|---|---|
| Corn | 33.16 | 37.45 |
| Wheat | 33.00 | 31.91 |
| Soybean meal, 43% | 23.05 | 19.22 |
| Fish meal, 64.6% | 3.62 | 3.74 |
| Soybean oil | 3.60 | 4.50 |
| Dicalcium phosphate | 1.17 | 1.09 |
| Limestone | 1.24 | 1.05 |
| Salt | 0.30 | 0.30 |
| L-lysine HCl, 78% | 0.12 | 0.11 |
| DL-methionine, 98% | 0.16 | 0.05 |
| L-threonine, 98% | 0.08 | 0.08 |
| Vitamin-mineral premix | 0.50 | 0.50 |
| Total | 100.00 | 100.00 |
| Metabolizable energy, kcal/kg | 3,050 | 3,150 |
| Crude protein | 20.53 | 18.95 |
| Calcium | 1.00 | 0.90 |
| Total phosphorous | 0.68 | 0.65 |
| Lysine | 1.10 | 1.00 |
| Methionine | 0.50 | 0.38 |
Vitamin A, 11,000 IU; vitamin D, 3,025 IU; vitamin E, 22 mg; vitamin K3, 2.2 mg; thiamine, 1.65 mg; riboflavin, 6.6 mg; pyridoxine, 3.3 mg; cobalamin, 17.6 μg; nicotinic acid, 22 mg; pantothenic acid, 13.2 mg; folic acid, 0.33 mg; biotin, 88 μg; choline chloride, 500 mg; iron, 48 mg; zinc, 96.6 mg; manganese, 101.76 mg; copper, 10 mg; selenium, 0.05 mg; iodine, 0.96 mg; and cobalt, 0.3 mg.
Values are calculated according to NRC.
Effects of AT-xynA on growth performance of broilers.
| Items | days 0–7 | days 7–14 | days 14–21 | days 21–42 | SEM | Value of | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CON | XY | CON | XY | CON | XY | CON | XY | Diet | Age | Diet*Age | ||
| Average daily gain, g/d | 14.12 | 14.55 | 20.53 | 21.62 | 37.28 | 40.34 | 51.57 | 60.10 | 0.96 | <0.01 | <0.01 | <0.01 |
| Average daily feed intake, g | 15.00 | 15.18 | 22.28 | 23.30 | 56.18 | 56.38 | 89.61 | 98.89 | 1.57 | 0.030 | <0.01 | 0.014 |
| Feed conversion ratio | 1.06 | 1.04 | 1.09 | 1.08 | 1.52 | 1.40 | 1.65 | 1.74 | 0.04 | 0.056 | <0.01 | 0.482 |
CON (n = 8) is AT-xynA un-supplemented group; XY (n = 8) is 4,000 U/kg AT-xynA supplemented group.
Means with a row with no common superscript differ significantly.
Figure 1Representative histological micrographs of ileum in broilers. CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Effects of AT-xynA on ileal morphology of broilers.
| Items | CON | XY | Value of |
|---|---|---|---|
| Villus height, μm | 293.40 ± 13.80 | 359.20 ± 13.94 | 0.015 |
| Crypt depth, μm | 64.26 ± 7.38 | 71.86 ± 11.19 | 0.592 |
| Villus height to crypt depth ratio | 4.72 ± 0.51 | 5.37 ± 0.79 | 0.513 |
| Villus height, μm | 428.80 ± 18.56 | 688.00 ± 12.02 | 0.097 |
| Crypt depth, μm | 85.82 ± 7.75 | 116.40 ± 14.77 | 0.104 |
| Villus height to crypt depth ratio | 5.12 ± 0.39 | 5.79 ± 0.51 | 0.331 |
| Villus height, μm | 492.70 ± 16.23 | 586.00 ± 31.51 | 0.010 |
| Crypt depth, μm | 95.98 ± 7.42 | 113.70 ± 1.25 | 0.136 |
| Villus height to crypt depth ratio | 5.21 ± 0.45 | 5.16 ± 0.21 | 0.930 |
| Villus height, μm | 792.40 ± 19.21 | 838.90 ± 28.67 | 0.214 |
| Crypt depth, μm | 113.90 ± 7.15 | 110.10 ± 5.34 | 0.680 |
| Villus height to crypt depth ratio | 7.08 ± 0.52 | 7.73 ± 0.59 | 0.437 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± standard error of the mean (SEM), n = 6.
Figure 2Effects of AT-xynA on alpha diversity of ileal microbiota in broilers. (A) Observed richness (Sobs), (B) Shannon diversity index (Shannon), (C) ACE estimator (Ace) (D) Chao 1 estimator (Chao) (E) Good’s coverage (Coverage), and (F) phylogenetic diversity (PD) of ileal microbiota in broilers on days 21 and 42. CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group. The “*” indicates a significant difference between the two treatments (p < 0.05).
Figure 3Effects of AT-xynA on ileal microbiota composition at the phylum level. (A,C) Ileal microbiota composition at the phylum level in broilers; (B,D) alterations of the abundance of bacterial phyla found in the ileum of broilers. CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group. The “*” indicates a significant difference between the two treatments (p < 0.05).
Figure 4Effects of AT-xynA on ileal microbiota composition at the family level. (A,C) Ileal microbiota composition at the family level with the relative abundance higher than 0.1% in broilers; (B,D) alterations of the abundance of bacterial families found in the ileum of broilers. CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group. The “*” indicates a significant difference between the two treatments (p < 0.05).
Figure 5Effects of AT-xynA on ileal microbiota composition at the genus level. (A,B) Ileal bacterial community heatmap at the genus level; (C,D) the analysis of different bacteria communities at the genus level in the cladogram of Linear discriminant analysis effect size between two groups. CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Prediction on metabolism of ileal bacterial communities using PICRUSt analysis.
| Items | CON | XY | Value of |
|---|---|---|---|
| Mineral absorption | 50.67 ± 3.89 | 435.30 ± 26.60 | 0.046 |
| Carbohydrate digestion and absorption | 3929.7 ± 263.4 | 1330.0 ± 184.9 | 0.034 |
| Butanoate metabolism | 104658 ± 1374 | 112353 ± 2842 | 0.693 |
| Starch and sucrose metabolism | 137024 ± 1714 | 118300 ± 2605 | 0.185 |
| Mineral absorption | 4.00 ± 0.08 | 73.33 ± 15.10 | 0.011 |
| Carbohydrate digestion and absorption | 2694.0 ± 123.5 | 719.7 ± 83.8 | 0.100 |
| Butanoate metabolism | 89377 ± 1545 | 58082 ± 1323 | 0.008 |
| Starch and sucrose metabolism | 118128 ± 3171 | 92262 ± 1704 | 0.081 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± SEM, n = 6.
Effects of AT-xynA on lactate and acetate concentrations in ileal digesta of broilers (mg/kg).
| Items | CON | XY | Value of |
|---|---|---|---|
| Lactate | 1029.20 ± 49.88 | 1174.70 ± 155.60 | 0.423 |
| Acetate | 531.40 ± 20.66 | 311.10 ± 32.29 | 0.039 |
| Lactate | 1992.60 ± 121.30 | 3054.20 ± 180.20 | 0.293 |
| Acetate | 424.70 ± 24.35 | 595.40 ± 48.20 | 0.411 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± SEM, n = 6.
Figure 6Effects of AT-xynA on antioxidant capacities in the ileum of broilers. (A) SOD, superoxide dismutase; (B) MDA, malondialdehyde concentrations in the ileum of broilers. CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Effects of AT-xynA on ileal immune function of broilers.
| Items | CON | XY | Value of |
|---|---|---|---|
| Interleukin-1β, pg./mg | 30.94 ± 2.02 | 23.37 ± 1.91 | 0.053 |
| Interleukin-6, ng/g | 11.25 ± 1.40 | 9.09 ± 0.19 | 0.262 |
| Interleukin-10, pg./mg | 3.42 ± 0.23 | 3.85 ± 0.63 | 0.553 |
| Tumor necrosis factor-α, ng/g | 34.47 ± 3.85 | 29.90 ± 4.17 | 0.466 |
| Interferon-γ, pg./mg | 3.32 ± 0.11 | 3.30 ± 0.58 | 0.978 |
| Interleukin-1β, pg./mg | 29.24 ± 4.05 | 18.16 ± 0.90 | 0.056 |
| Interleukin-6, ng/g | 14.57 ± 1.22 | 9.27 ± 0.45 | 0.015 |
| Interleukin-10, pg./mg | 4.23 ± 0.56 | 3.17 ± 0.25 | 0.155 |
| Tumor necrosis factor-α, ng/g | 40.38 ± 5.32 | 27.15 ± 1.57 | 0.076 |
| Interferon-γ, pg./mg | 4.54 ± 0.70 | 3.72 ± 0.24 | 0.329 |
| Interleukin-1β, pg./mg | 42.54 ± 5.60 | 30.27 ± 1.92 | 0.107 |
| Interleukin-6, ng/g | 13.33 ± 2.59 | 9.28 ± 0.19 | 0.258 |
| Interleukin-10, pg./mg | 4.28 ± 0.29 | 4.63 ± 1.32 | 0.811 |
| Tumor necrosis factor-α, ng/g | 37.87 ± 2.79 | 36.97 ± 2.63 | 0.938 |
| Interferon-γ, pg./mg | 3.96 ± 0.22 | 4.31 ± 0.97 | 0.740 |
| Interleukin-1β, pg./mg | 43.17 ± 3.51 | 29.37 ± 3.38 | 0.047 |
| Interleukin-6, ng/g | 12.31 ± 1.07 | 8.62 ± 1.03 | 0.067 |
| Interleukin-10, pg./mg | 4.09 ± 0.86 | 4.57 ± 1.13 | 0.753 |
| Tumor necrosis factor-α, ng/g | 49.41 ± 1.10 | 25.32 ± 3.58 | 0.108 |
| Interferon-γ, pg./mg | 3.87 ± 0.84 | 4.33 ± 0.83 | 0.716 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± SEM, n = 6.
Effects of AT-xynA on relative mRNA expression of ileal tight junction genes in broilers.
| Items | CON | XY | Value of |
|---|---|---|---|
| 1.00 ± 0.18 | 0.80 ± 0.01 | 0.584 | |
| Occludin | 1.00 ± 0.17 | 0.74 ± 0.06 | 0.458 |
| 1.00 ± 0.13 | 1.41 ± 0.14 | 0.169 | |
| Occludin | 1.00 ± 0.14 | 1.40 ± 0.11 | 0.162 |
| 1.00 ± 0.14 | 1.02 ± 0.12 | 0.881 | |
| Occludin | 1.00 ± 0.12 | 1.00 ± 0.09 | 0.937 |
| 1.00 ± 0.09 | 1.11 ± 0.05 | 0.323 | |
| Occludin | 1.00 ± 0.06 | 1.21 ± 0.14 | 0.438 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± SEM, n = 6. The values were calculated relative to the expression of β-actin with formula 2−ΔΔCt. ZO-1, zonula occludens-1.
Effects of AT-xynA on ileal endocrine peptide concentrations of broilers.
| Items | CON | XY | Value of |
|---|---|---|---|
| Epidermal growth factor, pg./mg | 23.45 ± 3.02 | 18.10 ± 0.26 | 0.217 |
| Glucagon-like peptide-1, pmol/g | 0.69 ± 0.04 | 0.89 ± 0.08 | 0.098 |
| Glucagon-like peptide-2, pg./mg | 200.70 ± 26.26 | 156.50 ± 7.41 | 0.181 |
| Insulin-like growth factor-1, ng/mg | 17.43 ± 1.36 | 21.95 ± 1.53 | 0.093 |
| Epidermal growth factor, pg./mg | 21.37 ± 2.27 | 18.66 ± 1.98 | 0.420 |
| Glucagon-like peptide-1, pmol/g | 0.71 ± 0.02 | 0.99 ± 0.12 | 0.141 |
| Glucagon-like peptide-2, pg./mg | 153.20 ± 4.77 | 153.20 ± 22.33 | 1.000 |
| Insulin-like growth factor-1, ng/mg | 17.17 ± 0.19 | 22.39 ± 2.34 | 0.157 |
| Epidermal growth factor, pg./mg | 25.34 ± 1.36 | 24.57 ± 7.26 | 0.926 |
| Glucagon-like peptide-1, pmol/g | 0.73 ± 0.02 | 1.12 ± 0.15 | 0.118 |
| Glucagon-like peptide-2, pg./mg | 201.70 ± 12.91 | 213.10 ± 12.73 | 0.843 |
| Insulin-like growth factor-1, ng/mg | 16.87 ± 1.45 | 28.68 ± 4.72 | 0.075 |
| Epidermal growth factor, pg./mg | 21.21 ± 7.87 | 24.53 ± 2.00 | 0.703 |
| Glucagon-like peptide-1, pmol/g | 1.08 ± 0.34 | 0.88 ± 0.09 | 0.600 |
| Glucagon-like peptide-2, pg./mg | 181.70 ± 6.71 | 194.70 ± 4.87 | 0.853 |
| Insulin-like growth factor-1, ng/mg | 21.17 ± 7.84 | 22.24 ± 1.71 | 0.905 |
CON is AT-xynA un-supplemented group; XY is 4,000 U/kg AT-xynA supplemented group.
Values are expressed as means ± SEM, n = 6.
Figure 7Heatmap of spearman’s correlation between ileal microbiota, metabolites, morphology, and immune factors. The correlation was analyzed based on the relative abundance of 30 phylotypes at genus level. The blue suggests a negative correlation, and the red suggests a positive correlation. The “*” indicates 0.01< p ≤ 0.05, “**” indicates 0.001< p ≤ 0.01, and “***” indicates p ≤ 0.001.